With free access, Aimedis will help connect patients directly to other patients and healthcare services, whether they’re from healthcare centers, pharmaceutical companies or scientific research facilities
“Health Comes First” Is a quote that all communities around the world approve, this indicates that health is the most important factor in life, which lies as evidence to continuous growth of global healthcare industry over recent decades, driven by the increase of world population at a rapid pace, continuous development of clinical innovations, government support, and social technology continues to fuel the industry’s growth across the world.
Yet, there seems to be a couple of issues that patients around the world suffer from while seeking attention from this industry, first thing is the cost implied on the medical services, global healthcare expenditure reached a staggering US$7 trillion in 2015, and it is projected to reach a total US$8.7 trillion by 2020 , therefore, a patient these days counts to ten before considering making a trip to the doctor.
In order to rein the rising costs in healthcare, patients with seemingly minor symptoms began avoiding human consultation, by breaking these traditional barriers to self-diagnosing through online consultation using search engines, being the more affordable and time-saving option.
However, residing to self-diagnosing is not always efficient, as it could make the patient feel worse, some other rising concerns with this way of medical consultation indicated that third parties track the patient’s data for their own commercial benefits, that might mislead the patient to false medical recommendations .
This is where Aimedis comes in, the blockchain startup has innovated a solution to bring patients, doctors, scientists and pharmaceutical professionals into a secure decentralized platform, where a solution is presented to bridge the traditional efficient medical practice, with the affordable and time saving consultation service, being the only existing medical ecosystem combining professional healthcare knowledge with the swarm intelligence of patient communities.
The Aimedis social platform “AIMsocial” will be accessible for free, where participants will be able to post and share useful information, provided with a secure voting system that supports the credibility of each post, while contributors who post useful and qualitative content will be incentivized in Aimedis’ token, so-called AIM token.
Dr. Michael Kaldasch, CEO and Founder of Aimedis, commented on the solution that Aimedis is providing, saying “Aimedis will not only revolutionize the way patients, doctors and other caregivers communicate and exchange data but will bring 2 major success factors of modern healthcare to the table – incentives and decentralization. Our dual blockchain model will represent each of these factors. The AIMchain will bring decentralization while the AIM token will incentivize patients and caregivers and generate an innovative and cost cutting way of paying for medical services.”
Aimedis platform is live from the 31st of May 2018 and can be visited on https://aimedis.com.
**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.